CME集团Q3 2026营收/EPS双创三季度纪录并小幅超预期，但系当日已多次处理财报的AI综述转述、无新增事实

Introduction & Market Context
CME Group Inc. (NASDAQ:CME) presented its third-quarter 2026 earnings results on October 21, 2026, reporting record quarterly revenue and strong double-digit growth across all major metrics. The exchange operator’s presentation highlighted broad-based strength driven by global market volatility, expanding international participation, and an aggressive product innovation strategy.
The company’s actual results slightly exceeded analyst expectations, with adjusted earnings per share of $3.02 beating the $2.98 consensus estimate and revenue of $1.74 billion topping the $1.71 billion forecast. However, shares slipped 1% in premarket trading to $292.37, suggesting investors had largely priced in the strong performance.
Quarterly Performance Highlights
CME Group delivered exceptional third-quarter results, with revenue climbing 13% year-over-year to $1.7 billion, marking the highest third-quarter revenue in company history. Adjusted diluted earnings per share reached $3.02, up 13% from the prior year, while adjusted operating income increased 15% to $1.2 billion.
As shown in the following chart tracking key financial metrics over time, the company demonstrated consistent upward momentum across revenue, operating expenses, and earnings per share from Q3 2023 through Q3 2026.
Average daily volume reached 29.4 million contracts, the highest third-quarter level on record and up 16% year-over-year. Notably, July and September 2026 set all-time monthly ADV records, with September reaching 31.8 million contracts, up 22% year-over-year.
All six asset classes posted double-digit growth rates. Financials ADV increased 16% to 23.8 million contracts, while Commodities ADV rose 16% to 5.6 million. The company also achieved record open interest of 128.2 million contracts at quarter-end, up 16% from 2025 year-end, with both Interest Rates and Foreign Exchange asset classes hitting Large Open Interest Holders records during the quarter.
Revenue and Earnings Analysis
The company’s revenue performance was driven by strong clearing and transaction fee revenue, which totaled $1.4 billion in the quarter, representing a 12% increase year-over-year. The revenue mix demonstrated balanced growth across product categories, as illustrated in the following breakdown.
Market data revenue emerged as a particular bright spot, reaching a record $243 million, up 20% from the prior year. This marked the 34th consecutive quarter of market data revenue growth, driven by subscriber expansion, new products and tools, and a price increase that took effect in January 2026.
The company maintained strong profitability with an adjusted operating margin of 69.4% and adjusted operating expenses of $532 million, or $428 million excluding license fees. For the full year, management expects adjusted operating expenses (excluding license fees) to be approximately $1.695 billion.
Global Expansion and Market Share
International growth accelerated significantly during the quarter, with non-U.S. average daily volume reaching 9 million contracts, up 22% year-over-year. The company reported double-digit growth across all geographic regions, with EMEA up 20%, APAC up 28%, Latin America up 24%, and Canada up 21%.
The following chart illustrates the strong trajectory of international trading activity and the regional distribution of growth, alongside the company’s margin efficiency offerings that provided clients with average daily savings exceeding $100 billion.
Energy products showed particularly strong international appeal, with 40% year-over-year growth in non-U.S. activity, followed by Agricultural products at 28% and Equity Index at 24%. The percentage of Energy ADV originating outside the U.S. increased from 30% in Q3 2025 to 37% in Q3 2026, demonstrating the company’s expanding global footprint.
Product Line Performance
The Financials segment, representing the largest portion of CME’s business, showed robust momentum across all major categories. Interest Rates ADV reached 15.1 million, up 13%, with particular strength in Treasuries, where ADV increased 25% to 9.4 million contracts.
As shown in the following historical trend of Financials trading volume, the company has demonstrated consistent growth from 7 million contracts in 2016 to 25.5 million year-to-date in 2026.
Equity Index ADV surged 23% to 7.7 million contracts, with Micro E-mini Nasdaq 100 futures doubling to a record 2.6 million ADV. The segment generated average daily margin savings of $47 billion for clients. Foreign Exchange ADV increased 19% to 988,000 contracts, including 49% growth in Japanese Yen futures.
Commodities showed continued global strength, with Agricultural products ADV up 18% to 2 million contracts and revenue up 14%. Energy ADV increased 16% to 2.7 million, while Metals ADV rose 13% to 935,000 contracts.
Strategic Initiatives and Innovation
CME Group significantly expanded its product portfolio during the quarter, emphasizing innovation tailored to both institutional and retail participants. The company commenced 24/7 trading for 1-Oz Gold and 100-Oz Silver futures following its second-quarter Cryptocurrency launch, with weekend trading volumes showing strong adoption.
Single Stock futures, launched July 27, traded nearly 350,000 contracts representing $3.4 billion in notional value since inception, with average daily open interest reaching 16,000 contracts in September. The product is now available on over 12 retail platforms.
The company’s Micro products strategy continued to gain traction, with total Micro ADV up 50% to 4.8 million contracts in Q3 2026. The following chart demonstrates the rapid growth trajectory of both Micro products and OTC Alternative products.
E-nano Equity Index futures, launched August 24, achieved 37,000 ADV in September and accelerated to 66,000 ADV through mid-October. The company also announced several pending launches, including Compute futures (pending regulatory review), Treasury Link for Q4 2026, and CME Securities Clearing Inc. scheduled for December 7, 2026.
Cloud migration efforts remained on track, with the company completing initial performance testing for CME Globex in the cloud and making ahead-of-schedule progress on the Aurora Cloud Region construction.
Fourth Quarter Momentum and Outlook
The strong third-quarter performance carried into the fourth quarter, with October 2026 ADV tracking at record levels. Through October 20, total ADV reached 29.7 million contracts, up 17% year-over-year, with particularly strong growth in Interest Rates (up 37% to 14.9 million) and Agricultural Commodities (up 23% to 2 million).
The following data illustrates both the strong start to Q4 2026 and the increasing frequency of high-volume trading days exceeding 30 million contracts.
For full-year 2026, ADV through October 20 reached 31.6 million contracts, up 12% from the record 2025 levels. Management noted that the company is "firmly on track to deliver another record year."
The company expects transaction fee changes implemented April 1 and the January 1 market data fee adjustment to increase total revenue by 1.0%-1.5% on similar activity to 2025, with additional October 1 transaction fee changes adding approximately 0.5%-1% to clearing and transaction fees on a full-year basis.
Financial Position and Shareholder Returns
CME Group maintained a strong financial position with approximately $2.4 billion in cash at quarter-end. The company returned nearly $1 billion to shareholders during the quarter through $465 million in regular dividends and $524 million in share repurchases, completing the return of proceeds from the OSTTRA sale.
Capital expenditures totaled approximately $15 million for the quarter, with full-year capital expenditures (net of leasehold improvement allowances) expected to be around $85 million. The adjusted effective tax rate of 23.8% came in at the low end of the company’s 23.5%-24.5% guidance range.
Year-to-date through Q3 2026, the company achieved record financial results with revenue up 9% to $5.3 billion, adjusted operating income up 10% to $3.8 billion, and adjusted net income up 11% to $3.4 billion.
Market Reaction and Valuation
Despite the strong quarterly results and raised outlook, CME shares declined 1% to $292.37 in premarket trading following the October 21 announcement. The muted reaction suggests investors had largely anticipated the strong performance, given the company’s consistent track record and the elevated volatility environment that typically benefits exchange operators.
The stock remains well above its 52-week low of $218.31 but trades approximately 11.3% below its 52-week high of $329.16. According to InvestingPro analysis, the shares trade at a P/E ratio of 25 with a PEG ratio of 1.76, suggesting a slight overvaluation relative to fair value estimates.
Forward-Looking Statements
Management emphasized the company’s positioning to benefit from continued global market volatility, shifting central bank policies, and geopolitical uncertainty. Chairman and CEO Terry Duffy stated that "global participants continue to turn to CME Group in record numbers" against this backdrop.
The company’s innovation pipeline remains robust, with multiple product launches planned for late 2026 and early 2027, including Compute Futures (pending regulatory approval), Wind Power futures and options, additional cryptocurrency products (Bitcoin Cash and Uniswap futures), Tungsten futures, and new European dairy contracts.
However, management acknowledged potential risks including regulatory delays that could slow new product launches, sensitivity to changes in market volatility levels, and competition from offshore and unregulated trading venues, particularly in 24/7 products. The company also noted that broader banking infrastructure evolution will be necessary to fully realize the potential of round-the-clock markets.
With fourth-quarter volume tracking 17% ahead of the prior year’s record and full-year volume running 12% ahead of 2025’s record levels, CME Group appears well-positioned to deliver another year of record financial performance while continuing to expand its product suite and global reach.
Full presentation:
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.